Passa al contenuto
Merck
Tutte le immagini(1)

Key Documents

View All Documentation

47317

Sigma-Aldrich

Fmoc-Lys(Fmoc)-OH

≥98.0% (HPLC)

Sinonimo/i:

Nα,Nε-di-Fmoc-L-lysine

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
Tutte le immagini(1)

About This Item

Formula empirica (notazione di Hill):
C36H34N2O6
Numero CAS:
78081-87-5
Peso molecolare:
590.66
Beilstein:
6034060
Numero MDL:
MFCD00080275
Codice UNSPSC:
12352209
ID PubChem:
57650922
NACRES:
NA.26

Saggio

≥98.0% (HPLC)

Impiego in reazioni chimiche

reaction type: Fmoc solid-phase peptide synthesis

applicazioni

peptide synthesis

Gruppo funzionale

Fmoc

Temperatura di conservazione

2-8°C

Stringa SMILE

OC(=O)[C@H](CCCCNC(=O)OCC1c2ccccc2-c3ccccc13)NC(=O)OCC4c5ccccc5-c6ccccc46

InChI

1S/C36H34N2O6/c39-34(40)33(38-36(42)44-22-32-29-17-7-3-13-25(29)26-14-4-8-18-30(26)32)19-9-10-20-37-35(41)43-21-31-27-15-5-1-11-23(27)24-12-2-6-16-28(24)31/h1-8,11-18,31-33H,9-10,19-22H2,(H,37,41)(H,38,42)(H,39,40)/t33-/m0/s1
BMJRTKDVFXYEFS-XIFFEERXSA-N

Categorie correlate

Codice della classe di stoccaggio

11 - Combustible Solids

Classe di pericolosità dell'acqua (WGK)

WGK 3

Punto d’infiammabilità (°F)

Not applicable

Punto d’infiammabilità (°C)

Not applicable

Dispositivi di protezione individuale

Eyeshields, Gloves, type N95 (US)

Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number
BCBW9055
BCBF8531V
BCBT4641
BCBR8529V
BCBM7845V

Non trovi la versione di tuo interesse?

Se hai bisogno di una versione specifica, puoi cercare il certificato tramite il numero di lotto.

Cerca un COA

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

I clienti hanno visto anche

Slide 1 of 8

1 of 8

Fmoc-azidolysine Novabiochem®

Sigma-Aldrich

8.52326

Fmoc-azidolysine

Fmoc-Lys(Dde)-OH Novabiochem®

Sigma-Aldrich

8.52057

Fmoc-Lys(Dde)-OH

Fmoc-Glu(O-2-PhiPr)-OH Novabiochem®

Sigma-Aldrich

8.52085

Fmoc-Glu(O-2-PhiPr)-OH

Fmoc-Lys(Ac)-OH Novabiochem®

Sigma-Aldrich

8.52042

Fmoc-Lys(Ac)-OH

Boc-Lys(Fmoc)-OH Novabiochem®

Sigma-Aldrich

8.53019

Boc-Lys(Fmoc)-OH

Fmoc-Lys(palmitoyl)-OH 95%

Sigma-Aldrich

772453

Fmoc-Lys(palmitoyl)-OH

Boc-Lys-OH 99%

Sigma-Aldrich

359688

Boc-Lys-OH

Fmoc-Lys(Boc)-OH Novabiochem®

Sigma-Aldrich

8.52012

Fmoc-Lys(Boc)-OH

Joseph R Merrill et al.
Biomaterials, 84, 241-249 (2016-02-04)
Tumor angiogenesis, the formation of new tumor blood supply, has been recognized as a hallmark of cancer and represents an important target for clinical management of various angiogenesis-dependent solid tumors. Previously, by screening a bacteriophage peptide library we have discovered
Shafq Al-Azzawi et al.
International journal of molecular sciences, 19(10) (2018-10-21)
Alzheimer's disease (AD) is a progressive brain disorder and age-related disease characterised by abnormal accumulation of β-amyloid (Aβ). The development of drugs to combat AD is hampered by the lack of therapeutically-active molecules able to cross the blood-brain barrier (BBB).
Alex Abramov et al.
Molecules (Basel, Switzerland), 24(1) (2018-12-24)
In this work we have investigated the potential benefits of using supramolecular gel networks as reaction media to carry out air-sensitive metal-free light-induced trifluoromethylation of six-membered (hetero)arenes under aerobic conditions. This reaction was performed at room temperature (RT) using sodium
Andrew G Cheetham et al.
Acta pharmacologica Sinica, 38(6), 874-884 (2017-03-07)
The conjugation of small molecular hydrophobic anticancer drugs onto a short peptide with overall hydrophilicity to create self-assembling drug amphiphiles offers a new prodrug strategy, producing well-defined, discrete nanostructures with a high and quantitative drug loading. Here we show the
Martina Tripepi et al.
Bioconjugate chemistry, 29(4), 1428-1437 (2018-02-23)
Molecular imaging requires the specific accumulation of contrast agents at the target. To exploit the superb resolution of MRI for applications in molecular imaging, gadolinium chelates, as the MRI contrast agents (CA), have to be conjugated to a specific vector
Visualizza tutti i documenti correlati

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.